NCT02700321 - Benefits of High Flow Nasal Cannula Oxygen for Preoxygenation During Intubation in Non Severely Hypoxemic Patients | Biotech Hunter

Enrollment

192

Participants

Timeline

Start Date

April 28, 2016

Primary Completion Date

June 27, 2017

Study Completion Date

October 5, 2017

Conditions

Need for Intubation, No Severe Hypoxemia

Interventions

DEVICE

OPTIFLOW/ AIRVO

"Patients randomized in HFNC group will received a four minutes preoxygenation period with Nasal High Flow Therapy (HFT) Optiflow ®/AIRVO® (60 l/mn FIO2 = 1) before orotracheal intubation under laryngoscopy after crash induction."

PROCEDURE

STANDARD Face Mask

"Patients randomized in STANDARD Face Mask group will received a four minutes preoxygenation period with a standard face mask (15 l/mn) before orotracheal intubation under laryngoscopy after crash induction."

Trial Locations (8)

29609

Brest hospital, CHU La cavale Blanche, medical intensive care unit, Brest

35033

Rennes university hospital, Hôpital Pontchaillou, medical intensive care unit, Rennes

37044

Tours university hospital, hôpital Bretonneau, medical intensive care unit, Tours

44093

Nantes university hospital, hôtel Dieu, Anesthesia intensive care unit, Nantes

Nantes University Hospital, Hôtel Dieu, Medical intensive care unit, Nantes

44800

Nantes University hospital, Hôpital Laennec, pneumology intensive care unit, Saint-Herblain

72033

Ch Le Mans, Le Mans

85925

CHD LES OUDOUAIRIES Service de réanimation polyvalente, La Roche-sur-Yon

All Listed Sponsors

lead

Nantes University Hospital

OTHER